Lv4
650 积分 2024-11-28 加入
Luspatercept in lower-myelodysplastic syndromes (MDS): Real-world data from the Gruppo Romano-Laziale Mielodisplasie (GROM-L) and review of literature
11天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
2个月前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
2个月前
已完结
Post-marketing safety concerns with luspatercept: a disproportionality analysis of the FDA adverse event reporting system
4个月前
已完结
Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study
4个月前
已完结
Long-term treatment of SOD1 ALS with tofersen: a multicentre experience in 17 patients
8个月前
已完结
皖公网安备34019202002308
